No black box warning on record for Polyethylene Glycol-3350 And Electrolytes

As of the latest FDA labeling reviewed, Polyethylene Glycol-3350 And Electrolytes (POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES) does not carry a black box warning. Standard warnings and precautions still apply — see the full Polyethylene Glycol-3350 And Electrolytes medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of fluid and electrolyte abnormalities: Encourage adequate hydration, assess concurrent medications, and consider laboratory assessments prior to and after use. ( 5.1 , 5.2 , 7.1 ) Cardiac arrhythmias: Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias. ( 5.2 ) Seizures: Use caution in patients with a history of

No black box warning on record for Polyethylene Glycol-3350 And Electrolytes

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of fluid and electrolyte abnormalities: Encourage adequate hydration, assess concurrent medications, and consider laboratory assessments prior to and after use. ( 5.1 , 5.2 , 7.1 ) Cardiac arrhythmias: Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias. ( 5.2 ) Seizures: Use caution in patients with a history of

Polyethylene Glycol-3350 And Electrolytes Black Box Warning

No black box warning on record for Polyethylene Glycol-3350 And Electrolytes

Other warnings & precautions

Polyethylene Glycol-3350 And Electrolytes Black Box Warning

No black box warning on record for Polyethylene Glycol-3350 And Electrolytes

Other warnings & precautions